Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 52
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
Biagio Barone, Armando Calogero, Luca Scafuri, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2545-2545
Open Access | Times Cited: 52
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
Kristin Grabe-Heyne, Christof Henne, Paramananthan Mariappan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 32
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
Qilin Huai, Chenyu Luo, Peng Song, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4484-4498
Open Access | Times Cited: 30
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment
Wen-Gu Pan, Xiaoli Liu, Shuang‐De Liu
Medicine (2024) Vol. 103, Iss. 14, pp. e37590-e37590
Open Access | Times Cited: 3
A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and Nutritional Markers for Non–Muscle-Invasive Bladder Cancer
Dengxiong Li, Ruicheng Wu, Jie Wang, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 3, pp. 102061-102061
Closed Access | Times Cited: 2
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database
Annamaria Porreca, Marta Di Nicola, Giuseppe Lucarelli, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 3, pp. 69.e17-69.e25
Open Access | Times Cited: 2
Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends
Aya T. Shalata, Mohamed Shehata, Eric Van Bogaert, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5019-5019
Open Access | Times Cited: 9
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer
Francesco Claps, Giulio Rossin, Bas W.G. van Rhijn, et al.
Medicina (2023) Vol. 59, Iss. 5, pp. 926-926
Open Access | Times Cited: 4
Comparative analysis of amide proton transfer and diffusion-weighted imaging for assessing Ki-67, p53 and PD-L1 expression in bladder cancer
Jing‐Lu Li, Yun Xu, Yong‐Sheng Xiang, et al.
Academic Radiology (2024)
Closed Access | Times Cited: 1
Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study
K.-P. Zhang, X. Zhang, Qiuyu Zhang, et al.
The journal of nutrition health & aging (2022) Vol. 26, Iss. 9, pp. 847-855
Open Access | Times Cited: 6
Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data
Ryo Tsukamoto, Tomokazu Sazuka, Yoshinori Hattori, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1638-1638
Open Access | Times Cited: 3
Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer
Lukas Scheipner, Hanna Zurl, Julia V. Altziebler, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5770-5770
Open Access | Times Cited: 2
Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis
Daqing Tan, Jinze Li, Tianhai Lin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6261-6261
Open Access | Times Cited: 3
Effectiveness of integrated nursing interventions in enhancing patient outcomes during postoperative intravesical instillation for non-muscle invasive bladder cancer: A comparative study
Wenwen Wang, Ying Chen, Jun Gu
Medicine (2024) Vol. 103, Iss. 11, pp. e36871-e36871
Open Access
An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
Z. Khene, Yair Lotan
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 415-423
Closed Access
The upregulation of POLR3G correlates with increased malignancy of bladder urothelium
Xianhui Liu, Lin Zhu, Diancheng Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Urologist’s role on smoking cessation counseling in patients presenting with asymptomatic hematuria: single academic institution experience
Fumihiko Nakamura, Lauren A Tranthem, Thomas Barefoot, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 8, pp. 1372-1377
Open Access
Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value
Ali Nebioğlu, Rojda Tanrıverdi, Mert Başaranoğlu, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access
Prognostic value of neutrophil-to-lymphocyte ratio in patients with non–muscle-invasive bladder cancer with intravesical Bacillus Calmette–Guérin immunotherapy: a systematic review and meta-analysis
Jiaguo Huang, Li Lin, Dikai Mao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Loss of MK2 Enhances Radiation-Mediated Apoptosis in Bladder Cancer
Deri Morgan, Kiersten L. Berggren, Grace Millington, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 6, pp. 871-881
Open Access
A prognostic model for bladder cancer based on cytoskeleton-related genes
Chunting Peng, Sufan Guo, Zheng Yang, et al.
Medicine (2023) Vol. 102, Iss. 17, pp. e33538-e33538
Open Access | Times Cited: 1
Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guérin
G. TRÉPANIER, Timo K. Nykopp, Raphaëlla Rosebush-Mercier, et al.
Clinical Genitourinary Cancer (2023) Vol. 22, Iss. 2, pp. 354-359.e1
Closed Access | Times Cited: 1
Longitudinal Transcription Profiling of Bladder Cancers Dictate the Response to BCG Treatment and Disease Progression
Seo-Young Lee, Yunhee Lee, Tae‐Min Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 144-144
Open Access
Page 1

Scroll to top